Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 1005) is a clinical research site located in Nashville, Tennessee, United States 37232.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 1005) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Carcinoma, Renal Cell.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 1005) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 1005) has 1 clinical trials on record, with 1 currently active. Their work covers Carcinoma, Renal Cell.
Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 1005) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.